↓ Skip to main content
What is this page? Embed badge

Cost-utility of ranibizumab versus aflibercept for treating Greek patients with visual impairment due to diabetic macular edema

Overview of attention for article published in Cost Effectiveness and Resource Allocation, April 2016
Altmetric Badge

About this Attention Score

  • In the top 25% of all research outputs scored by Altmetric
  • High Attention Score compared to outputs of the same age (81st percentile)

Mentioned by

twitter
13 X users

Citations

dimensions_citation
12 Dimensions

Readers on

mendeley
35 Mendeley
Summary X Dimensions citations

This page is provided by Altmetric.